Ashwani Singla

Ashwani Singla

Active Director Whole-Time Director DIN 01256240
DIN 01256240 First appointment Aug 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Past companies 2 historical roles
Total affiliations 10 Since Aug 2003
Shareholding value •••• Premium profile

About Ashwani Singla

Data last updated:

Ashwani Singla is a Whole-Time Director at Curetech Formulations Private Limited (since 2003), Director at Csc Pharmaceuticals Private Limited (since 2021) and Partner at Ralycos Llp (since 2019), and holds 5 more current directorships. The companies operate in Pharma, FMCG and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹121 Cr; the largest is Curetech Formulations Private Limited at ₹83.74 Cr (FY 2024). Earlier, Ashwani Singla was a Director at Healwell Pharmaceuticals Private Limited (2015–2017) and Director at Galen Infrastructure Limited (2019).

DIN 01256240
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 29 Aug 2003
Oldest Company Age 23 yrs
Largest company Curetech Formulations Private Limited · ₹83.74 Cr (FY 2024)
Combined revenue ₹121 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director29 Aug 20032003₹83.74 Cr (FY 2024)Active
Csc Pharmaceuticals Private Limited U51909HR2021PTC093973
Director24 Mar 20212021₹35.18 Cr (FY 2024)Active
Ralycos Llp AAK-9606
Partner28 Feb 20192017₹2.38 Cr (FY 2022)Active
Hne Healthcare Private Limited U52609HR2020PTC087001
Additional Director04 Apr 20222020₹2.8 Lakh (FY 2025)Active
Medira Healthcare Limited U21002HP2025PLC011844
Director17 Jul 20252025Active
Ellsoak Llp ACE-3918
Partner27 Apr 20242023Active
Nextmile Industries Private Limited U31001HR2023PTC110729
Director13 Apr 20232023Active
Vanachem Pharma Private Limited U51909PB2022PTC057422
Director12 Dec 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Mar 20152015₹13,094 (FY 2024)Active
Galen Infrastructure Limited U74999HP2017PLC006558
Director30 Mar 20192017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Curetech Formulations Private Limited
Csc Pharmaceuticals Private Limited
Hne Healthcare Private Limited
Ralycos Llp
Premium access

Shareholding and investment profile for Ashwani Singla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwani Singla

Ashwani Singla currently holds 8 directorships: Curetech Formulations Private Limited (Whole-Time Director, since 29 Aug 2003, revenue ₹83.74 Cr (FY 2024)); Csc Pharmaceuticals Private Limited (Director, since 24 Mar 2021, revenue ₹35.18 Cr (FY 2024)); Ralycos Llp (Partner, since 28 Feb 2019, revenue ₹2.38 Cr (FY 2022)); Hne Healthcare Private Limited (Additional Director, since 04 Apr 2022, revenue ₹2.8 Lakh (FY 2025)); Medira Healthcare Limited (Director, since 17 Jul 2025); and 3 more.

Ashwani Singla was first appointed on 29 Aug 2003 as Whole-Time Director at Curetech Formulations Private Limited. The most recent appointment on record is 17 Jul 2025 at Medira Healthcare Limited.

The 4 current companies of Ashwani Singla that report revenue have a combined latest revenue of ₹121 Cr: Curetech Formulations Private Limited ₹83.74 Cr (FY 2024); Csc Pharmaceuticals Private Limited ₹35.18 Cr (FY 2024); Ralycos Llp ₹2.38 Cr (FY 2022); Hne Healthcare Private Limited ₹2.8 Lakh (FY 2025).

Ashwani Singla held 2 earlier board appointments: Healwell Pharmaceuticals Private Limited (Director, 05 Mar 2015 to 18 Dec 2017); Galen Infrastructure Limited (Director, 30 Mar 2019 to 10 Jun 2019).

The current boards of Ashwani Singla's companies include Sumit Kumar (Curetech Formulations Private Limited), Mohit Mittal (Csc Pharmaceuticals Private Limited), Manu Wahi (Ralycos Llp), Rakesh Kumar Wahi (Ralycos Llp), Bharat Bhushan Jain (Hne Healthcare Private Limited), Naresh Jain (Hne Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available